An evaluation of usefulness of prostate specific antigen and digital rectal examination in the diagnosis of prostate cancer in an unscreened population:experience in a Nigerian teaching hospital.

OBJECTIVE To evaluate the usefulness of prostate specific antigen (PSA) and digital rectal examination (DRE) in the diagnosis of cancer of the prostate (CaP) amongst unscreened patients. PATIENTS, MATERIALS AND METHODS A prospective study 168 unscreened men who were referred for evaluation for CaP. They all had a 10-core extended transrectal prostatic needle biopsy using size 16 Tru Cut needle for either an elevated serum total PSA of > 4 ng/ml or abnormal DRE findings or both. Overall cancer detection rate was determined and detection rates were determined separately for patients with elevated PSA with normal DRE, abnormal DRE with normal PSA and those with both indications. The performances of each indication were determined separately and in combination in terms of their sensitivity, specificity, predictive values and accuracy. The results were compared amongst patients with different indications for biopsy. RESULTS The overall cancer detection rate was 44.0%. Detection rates in patients with elevated PSA with normal DRE and abnormal DRE with normal PSA were 30.0% and 17.4% respectively. There was statistically significant increased detection of 61.2% amongst patients with both indications. The overall sensitivities of PSA, DRE and combination of both were 94.6%, 75.7% and 70.3% respectively while the specificities were 20.2%, 44.7% and 64.9% respectively. The accuracies of PSA, DRE and combination of both indications were 53%, 58% and 67.3% respectively while the PPVs were 48.3%, 51.9% and 61.2% respectively. Mean Gleason score was 6.82 while the overall complication rate was 23.2% CONCLUSION Neither PSA nor DRE is sensitive, specific, predictive or accurate enough on its own to be an ideal screening or diagnostic test for CaP. Therefore, optimal evaluation of patients with suspected CaP is best achieved with both even in unscreened populations.

[1]  E. Olapade-Olaopa,et al.  Management of advanced prostate cancer in Africa. , 2008, The Canadian journal of urology.

[2]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[3]  A. Sanou,et al.  Prostate cancer outcome in Burkina Faso , 2011, Infectious Agents and Cancer.

[4]  G Bartsch,et al.  Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer. , 2001, Urology.

[5]  A. D'Amico,et al.  Prostate cancer : principles and practice , 2002 .

[6]  Peter L Choyke,et al.  Imaging prostate cancer: a multidisciplinary perspective. , 2007, Radiology.

[7]  F. Labrie,et al.  Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer , 2000, The Prostate.

[8]  B. Donnelly,et al.  Transrectal ultrasound-guided biopsy of the prostate: relation between ASA use and bleeding complications. , 1999, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[9]  Risks and Complications of Transrectal Ultrasound Guided Prostate Needle Biopsy: A Prospective Study and Review of the Literature , 1999 .

[10]  D. Osegbe.  Prostate cancer in Nigerians: facts and nonfacts. , 1997, The Journal of urology.

[11]  L. Borden,et al.  An abnormal digital rectal examination is an independent predictor of Gleason ≥7 prostate cancer in men undergoing initial prostate biopsy: a prospective study of 790 men , 2007, BJU international.

[12]  M. Ballal,et al.  Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer? , 2005, BJU international.

[13]  O. Shittu,et al.  Prostate specific antigen in the Nigerian African. , 2000, African journal of medicine and medical sciences.

[14]  J. Galić,et al.  Comparison of digital rectal examination and prostate specific antigen in early detection of prostate cancer. , 2003, Collegium antropologicum.

[15]  Jacques Ferlay,et al.  Estimates of the worldwide incidence of 25 major cancers in 1990 , 1999, International journal of cancer.

[16]  K. Tijani,et al.  Prostate diseases in Lagos, Nigeria: a histologic study with tPSA correlation. , 2011, Nigerian Postgraduate Medical Journal.

[17]  H. D. de Koning,et al.  Prostate cancer detection at low prostate specific antigen. , 2000, The Journal of urology.

[18]  P. J. van der Maas,et al.  Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. , 1999, Journal of the National Cancer Institute.

[19]  T. Rebbeck,et al.  A study of PSA values in an unselected sample of Senegalese men. , 2008, The Canadian journal of urology.

[20]  K. King,et al.  Digital rectal examination, serum prostate specific antigen, and prostatic ultrasound: How effective is this diagnostic triad? , 1994, Journal of surgical oncology.

[21]  E. Crawford,et al.  Efficiency of prostate‐specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age‐specific reference range as a cutoff for abnormal values , 1999, The Prostate.

[22]  T. H. van der Kwast,et al.  Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination. , 2001, Urology.

[23]  Louis R Kavoussi,et al.  Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. , 1994, The Journal of urology.

[24]  O. Shittu,et al.  Increased incidence of prostate cancer in Nigerians. , 1999, Journal of the National Medical Association.

[25]  R. Lamerz,et al.  Screening for prostatic carcinoma with prostate specific antigen. , 1997, Anticancer research.

[26]  J. Oesterling,et al.  Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. , 1991, The Journal of urology.

[27]  M. Brawer,et al.  Prostate‐specific antigen: Current status , 1999, CA: a cancer journal for clinicians.

[28]  W. Catalona,et al.  What is the role of digital rectal examination in men undergoing serial screening of serum PSA levels? , 2009, Nature Clinical Practice Urology.

[29]  Georg Bartsch,et al.  Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores. , 2004, The Journal of urology.